PFD ( DrugBank: - )

---

3 diseases

ID	Disease name (Link within this page)	Number of trials
51	Scleroderma	1
117	Syringomyelia	1
298	Hereditary pancreatitis	2

51. Scleroderma

---

Clinical trials : 525 /  Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03221257 (ClinicalTrials.gov)	November 28, 2017	12/7/2017	Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate	Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease	Scleroderma, Systemic;Interstitial Lung Disease	Drug: Pirfenidone (PFD);Drug: Placebo (Plac);Drug: Mycophenolate Mofetil (MMF)	Michael Roth	University of Michigan;Genentech, Inc.;University of California, Los Angeles	Completed	18 Years	N/A	All	51	Phase 2	United States

117. Syringomyelia

---

Clinical trials : 3 /  Drugs : 5 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000039678	2021-02-01	2020-11-05	Evaluation of Posterior Fossa Decompression (PFD) without or with Cerebellar Tonsil Thermocoagulation (PFDCT) for Arnold-Chiari Malformation Type I with Syringomyelia: a ramdomised controlled trial	Evaluation of Posterior Fossa Decompression (PFD) without or with Cerebellar Tonsil Thermocoagulation (PFDCT) for Arnold-Chiari Malformation Type I with Syringomyelia: a ramdomised controlled trial	Arnold-Chiari Malformation Type I with Syringomyelia	A Group:Posterior Fossa Decompression;B Group:Posterior Fossa Decompression (PFD) with Cerebellar tonsil Thermocoagulation (PFDCT);	Fujian Medical University Union Hospital	NULL	Recruiting	18	65	Both	A Group:70;B Group:70;		China

298. Hereditary pancreatitis

---

Clinical trials : 95 /  Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000028150	2017/07/10	10/07/2017	Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker	Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker - Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker	Healthy volunteers, patients with chronic pancreatitis, patients with chronic hepatitis	Blood test and PFD test	Yokohama City University	NULL	Recruiting	20years-old	75years-old	Male and Female	200	Not selected	Japan
2	JPRN-UMIN000008340	2012/08/01	04/07/2012	pancreatic exocrine function with non-contrast MRI:Visualization by Means of MRCP with Spatially Selective Inversion-Recovery Pulse	pancreatic exocrine function with non-contrast MRI:Visualization by Means of MRCP with Spatially Selective Inversion-Recovery Pulse - pancreatic exocrine function using non-contrast MRI	Chronic pancreatitis	MRCP/PFD test MRCP	the Department of Diagnostic Radiology Kawasaki Medical School	NULL	Complete: follow-up complete	Not applicable	Not applicable	Male and Female	40	Not selected	Japan